The Chinese biopharmaceutical industry has reportedly entered an innovation phase (2.0), focusing on commercialising its products, which might lead to surpassing the US in pharmaceutical market leader...

Recent analyses have shown that China's pharmaceutical output has matched the United States, with new drug discoveries tripling from about 30 in 2013 to over 400 by a decade later. This achievement ma...

Chinese pharmaceutical companies have recently engaged in multiple out-licensing agreements with international partners, highlighting China’s increasing significance as a source for innovative medicin...

The pharmaceutical industry faces significant patent expirations between 2025 and 2030, potentially leading to substantial losses due to generic and biosimilar competition. The article explores whethe...

Roche's CEO, in an interview with Swiss media, advocates for Switzerland to increase drug prices to match those paid by the United States, following pressure from President Trump's tariff policies. Th...

HC Wainwright raised its target price for KalVista Pharmaceuticals (NASDAQ:KALV) stock from $27.00 to $37.00, maintaining a 'buy' rating. The analyst report was distributed to investors on Friday....

The EU's health-related policies and regulations have significantly benefited both the pharmaceutical and food industries. These sectors have seen advantages as a result of regulatory frameworks desig...

Chinese pharmaceutical company BeOne Medicines has appointed Wang Lai, the firm's global head of R&D since April 2021, to a new position as co-president. The appointment aims to bolster the company’s ...

UnitedHealth Group, Eli Lilly and Company, Thermo Fisher Scientific, Tempus AI, and Johnson & Johnson are highlighted as key medical stocks to observe today by MarketBeat's stock screener tool. These ...

BDF Gestion increased its stake in pharmaceutical company Abbott Laboratories by purchasing an additional 6,100 shares, bringing the total ownership to 64,861 shares as of their most recent filing wit...

Analysts at BTIG Research initiated coverage of Bicara Therapeutics stock on NASDAQ, assigning a 'buy' rating and setting a price target of $28.00 per share, which represents a potential upside of 56%...

In Q2 2023, Squarepoint Operations LLC increased its holdings of Vanda Pharmaceuticals Inc.'s stocks by acquiring an additional 75,295 shares, resulting in a total ownership of 153,345 shares with a v...

The US Food and Drug Administration has approved Novo Nordisk's pill version of Wegovy for daily use in treating obesity. This development strengthens Novo Nordisk's position against Eli Lilly, whose ...

Nine pharmaceutical companies have entered into agreements with the Trump administration to help lower drug prices for some Americans in exchange for a temporary suspension of threatened tariffs....